Get the Stockscreener App
6.07
14.27%
-1.01
Enveric Biosciences Inc stock is traded at $6.07, with a volume of 133.76K.
It is down -14.27% in the last 24 hours and down -26.94% over the past month.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
See More
Previous Close:
$7.08
Open:
$6.5
24h Volume:
133.76K
Relative Volume:
2.08
Market Cap:
$3.67M
Revenue:
-
Net Income/Loss:
$-15.08M
P/E Ratio:
-0.9455
EPS:
-6.42
Net Cash Flow:
$-11.56M
1W Performance:
-14.75%
1M Performance:
-26.94%
6M Performance:
-60.79%
1Y Performance:
-92.73%
1-Day Range:
$5.581
$6.645
1-Week Range:
$5.581
$8.61
52-Week Range:
$5.581
$96.30
Enveric Biosciences Inc Stock (ENVB) Company Profile
Name
Enveric Biosciences Inc
Sector
Industry
Phone
239-302-1707
Address
4851 TAMIAMI TRAIL N, SUITE 200, NAPLES
Compare ENVB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENVB
Enveric Biosciences Inc
|
6.09 | 3.67M | 0 | -15.08M | -11.56M | -6.42 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.10 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
629.40 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
425.02 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
837.26 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.55 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Enveric Biosciences Inc Stock (ENVB) Latest News
How resilient is Enveric Biosciences Inc. stock in market downturnsQuarterly Performance Summary & High Yield Equity Trading Tips - newser.com
Enveric Biosciences Inc. stock prediction for this week2025 Support & Resistance & Free Fast Gain Swing Trade Alerts - newser.com
Key metrics from Enveric Biosciences Inc.’s quarterly dataQuarterly Trade Summary & Community Consensus Trade Signals - newser.com
How Enveric Biosciences Inc. stock performs in high volatility marketsJuly 2025 Decliners & Weekly Breakout Watchlists - newser.com
How to interpret RSI for Enveric Biosciences Inc. stockProfit Target & Fast Gaining Stock Strategy Reports - newser.com
Why Enveric Biosciences Inc. (SLZ) stock could outperform next yearJuly 2025 PreEarnings & Real-Time Volume Surge Alerts - newser.com
Why hedge funds are buying Enveric Biosciences Inc. stockJuly 2025 Recap & Capital Efficiency Focused Ideas - newser.com
Why Enveric Biosciences Inc. stock could benefit from AI revolutionJuly 2025 Decliners & High Return Stock Watch Alerts - newser.com
Quantitative breakdown of Enveric Biosciences Inc. recent moveShare Buyback & Step-by-Step Trade Execution Guides - newser.com
Can Enveric Biosciences Inc. stock beat analyst upgradesLong Setup & Consistent Return Strategy Ideas - newser.com
Market reaction to Enveric Biosciences Inc.’s recent newsJuly 2025 WrapUp & Real-Time Volume Trigger Notifications - newser.com
Why Enveric Biosciences Inc. stock is a value investor pickExit Point & Entry Point Confirmation Signals - newser.com
Published on: 2025-11-03 03:28:07 - newser.com
Is Enveric Biosciences Inc. stock a smart buy before Fed meeting2025 Bull vs Bear & Comprehensive Market Scan Reports - newser.com
Sentiment analysis tools applied to Enveric Biosciences Inc.Weekly Investment Recap & Verified Stock Trade Ideas - newser.com
How to read the order book for Enveric Biosciences Inc.2025 Year in Review & Low Risk High Reward Trade Ideas - newser.com
Is this a good reentry point in Enveric Biosciences Inc.Portfolio Growth Summary & Stepwise Trade Execution Plans - newser.com
How to build a custom watchlist for Enveric Biosciences Inc.July 2025 News Drivers & Fast Entry Momentum Alerts - newser.com
Enveric Biosciences Inc (FRA:SLZ0) Stock PDF (Updated: 2025/11/02) - GuruFocus
Enveric Biosciences (STU:SLZ0) Earnings Yield (Joel Greenbl - GuruFocus
Enveric Biosciences (STU:SLZ0) YoY EBITDA Growth : 75.19% (As of Jun. 2025) - GuruFocus
Enveric Biosciences (STU:SLZ0) EBITDA per Share : €-114.12 (TTM As of Jun. 2025) - GuruFocus
Enveric Biosciences (STU:SLZ0) EV-to-EBIT : -0.01 (As of Nov. 02, 2025) - GuruFocus
Enveric Biosciences (STU:SLZ0) Other Stockholders Equity : €0.00 Mil (As of Jun. 2025) - GuruFocus
Enveric Biosciences (STU:SLZ0) Total Payout Yield % : -197.19 (As of Nov. 02, 2025) - GuruFocus
Is Enveric Biosciences Inc. (SLZ) stock cheap vs fundamentalsInflation Watch & Real-Time Chart Pattern Alerts - newser.com
Will Enveric Biosciences Inc. stock gain from government policiesJuly 2025 EndofMonth & High Conviction Buy Zone Picks - newser.com
Can Enveric Biosciences Inc. stock maintain growth trajectoryQuarterly Portfolio Review & Expert Curated Trade Setup Alerts - newser.com
Enveric Biosciences Inc Stock (ENVB) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.25%
0.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):